Chemicals · Founded 2001 · www.jgchem.com · BSE 544138 · NSE JGCHEM · ISIN INE0MB501011
No Notes Added Yet
Business
JG Chemicals Ltd. is a leading manufacturer of zinc oxide in India. The company's core business involves the production and sale of various grades of zinc oxide, which is a versatile inorganic compound used across a wide range of industries. It primarily operates on a B2B model, supplying its products as critical raw materials to other manufacturing companies. The company generates revenue through the sales of its zinc oxide products, catering to specific technical specifications and purity requirements of its diverse client base.
Revenue Mix
While JG Chemicals primarily focuses on zinc oxide manufacturing, its revenue mix is diversified by the end-user industries it serves rather than distinct product segments. Key applications for its zinc oxide include:
Rubber (Tyres & Industrial Rubber): Used as an activator in vulcanization and a reinforcing agent. This is typically a significant end-user segment.
Ceramics: As a fluxing agent and to improve mechanical strength and chemical resistance.
Paints & Coatings: For UV absorption, antifungal properties, and pigmentation.
Pharmaceuticals & Cosmetics: In ointments, lotions, sunscreens, and personal care products for its antiseptic and skin-protective properties.
Chemicals & Agrochemicals: Various industrial and agricultural applications.
The company produces over 80 different grades of zinc oxide, tailored for specific customer needs.
Industry
JG Chemicals operates within the broader Chemicals sector, specifically in the manufacturing of specialty inorganic chemicals. The zinc oxide industry, particularly in India, can be characterized by the presence of both organized and unorganized players. JG Chemicals is positioned as one of India's largest manufacturers of zinc oxide, holding a significant market share in the organized segment. Its long operational history and capacity position it as a key supplier to various industries, often competing on quality, consistency, and ability to meet specific client requirements.
MOAT
JG Chemicals benefits from several potential competitive advantages:
Scale and Operational Efficiency: As a large-scale producer, the company likely benefits from economies of scale in raw material procurement (zinc metal) and manufacturing, leading to cost efficiencies.
Established Customer Relationships: A long operational track record (over five decades) suggests deep-rooted relationships with major customers across diverse industries, leading to sticky client bases.
Product Diversification & Customization: The ability to produce over 80 grades of zinc oxide allows it to cater to specific and varied customer needs, enhancing customer loyalty and reducing reliance on a single product variant.
Technical Expertise: Specialized manufacturing processes and in-house R&D for developing customized grades provide a degree of technical expertise that can be difficult for new entrants to replicate quickly.
Growth Drivers
Growth in End-User Industries: Continued expansion of the automotive (tire), ceramics, pharmaceuticals, and personal care sectors in India and globally will drive demand for zinc oxide.
Capacity Expansion: Strategic investments in increasing manufacturing capacity to meet growing demand and capture a larger market share.
Diversification into New Applications: Research and development into new uses for zinc oxide (e.g., specialized electronics, catalysts) can open up new revenue streams.
Export Opportunities: Tapping into international markets to leverage global demand and enhance geographical diversification.
Shift from Unorganized to Organized Sector: Potential for market share gains as customers increasingly prefer reliable, quality-certified suppliers from the organized sector.
Risks
Raw Material Price Volatility: The primary raw material, zinc metal, is a commodity. Fluctuations in global zinc prices can impact profitability if not effectively managed through hedging or pass-through mechanisms.
Competition: Intense competition from existing domestic and international players, as well as the unorganized sector, could pressure pricing and margins.
Demand Cyclicality: Demand for zinc oxide is linked to industrial activity, making it susceptible to economic slowdowns in key end-user sectors like automotive or construction.
Environmental Regulations: Stricter environmental norms and compliance costs related to chemical manufacturing could impact operations and profitability.
Foreign Exchange Fluctuations: Given potential imports of raw materials or exports of finished goods, adverse movements in foreign exchange rates could pose a risk.
Management & Ownership
JG Chemicals is a promoter-led company with a long-standing family legacy in the chemicals business. The management team likely comprises experienced professionals with deep industry knowledge. The ownership structure typically involves significant promoter holdings, alongside participation from institutional investors and the public through its listing.
Outlook
JG Chemicals is well-positioned as a leading player in the Indian zinc oxide market, benefiting from its scale, diverse product portfolio, and established customer relationships. The company's growth outlook is tied to the expansion of its key end-user industries in India and potential for increasing its export footprint. However, its performance remains susceptible to the inherent volatility of commodity prices (zinc metal) and potential slowdowns in industrial demand. While its long operational history and technical expertise provide a defensive moat, navigating a competitive landscape and managing raw material costs will be crucial for sustained profitability.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 181 | 203 | 212 | 209 | 224 | 218 | 220 | 248 | 286 | 316 |
| Other Income | 3 | 0 | 3 | 3 | 4 | 3 | 4 | 3 | 5 | 3 |
| Total Income | 184 | 203 | 216 | 212 | 228 | 221 | 224 | 252 | 292 | 318 |
| Total Expenditure | 164 | 180 | 191 | 186 | 205 | 198 | 202 | 226 | 265 | 282 |
| Operating Profit | 20 | 23 | 25 | 26 | 23 | 23 | 22 | 26 | 27 | 36 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 18 | 21 | 23 | 24 | 22 | 22 | 20 | 25 | 25 | 35 |
| Provision for Tax | 5 | 5 | 6 | 6 | 6 | 5 | 5 | 6 | 7 | 9 |
| Profit After Tax | 14 | 16 | 17 | 18 | 16 | 16 | 15 | 18 | 19 | 26 |
| Adjustments | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Profit After Adjustments | 13 | 15 | 17 | 17 | 15 | 16 | 14 | 18 | 18 | 25 |
| Adjusted Earnings Per Share | 3.3 | 3.9 | 4.2 | 4.3 | 3.9 | 4 | 3.7 | 4.5 | 4.6 | 6.4 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 250 | 339 | 399 | 435 | 613 | 785 | 668 | 848 | 973 | 1070 |
| Other Income | 1 | 3 | 8 | 7 | 10 | 11 | 8 | 13 | 16 | 15 |
| Total Income | 251 | 343 | 408 | 442 | 623 | 796 | 676 | 861 | 989 | 1086 |
| Total Expenditure | 229 | 296 | 380 | 393 | 556 | 710 | 623 | 765 | 891 | 975 |
| Operating Profit | 22 | 47 | 27 | 49 | 67 | 85 | 53 | 97 | 98 | 111 |
| Interest | 6 | 6 | 6 | 5 | 7 | 5 | 4 | 1 | 1 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 3 | 5 | 5 | 5 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| Profit Before Tax | 14 | 38 | 19 | 41 | 57 | 77 | 43 | 90 | 92 | 105 |
| Provision for Tax | 5 | 13 | 5 | 12 | 14 | 20 | 11 | 23 | 23 | 27 |
| Profit After Tax | 9 | 25 | 14 | 29 | 43 | 57 | 32 | 67 | 69 | 78 |
| Adjustments | 0 | -2 | -1 | -5 | -3 | -2 | -1 | -3 | -3 | -4 |
| Profit After Adjustments | 9 | 23 | 13 | 23 | 40 | 55 | 31 | 64 | 66 | 75 |
| Adjusted Earnings Per Share | 2.9 | 7.3 | 4.1 | 7.4 | 12.6 | 17.3 | 7.9 | 16.3 | 16.8 | 19.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 15% | 7% | 17% | 0% |
| Operating Profit CAGR | 1% | 5% | 15% | 0% |
| PAT CAGR | 3% | 7% | 19% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 46% | NA% | NA% | NA% |
| ROE Average | 14% | 13% | 21% | 27% |
| ROCE Average | 19% | 18% | 23% | 26% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 31 | 54 | 85 | 108 | 153 | 208 | 398 | 465 | 528 |
| Minority's Interest | 0 | 2 | 5 | 11 | 4 | 6 | 7 | 10 | 13 |
| Borrowings | 14 | 8 | 6 | 5 | 6 | 7 | 4 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 6 | 0 | 0 | 0 | 1 | -0 | 1 | 3 |
| Total Current Liabilities | 56 | 56 | 53 | 85 | 102 | 77 | 39 | 22 | 26 |
| Total Liabilities | 102 | 126 | 149 | 210 | 264 | 298 | 448 | 498 | 569 |
| Fixed Assets | 14 | 14 | 21 | 23 | 22 | 35 | 42 | 39 | 67 |
| Other Non-Current Assets | 1 | 2 | 10 | 11 | 18 | 6 | 13 | 15 | 23 |
| Total Current Assets | 87 | 110 | 119 | 176 | 224 | 256 | 394 | 444 | 479 |
| Total Assets | 102 | 126 | 149 | 210 | 264 | 298 | 448 | 498 | 569 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 1 | 1 | 5 | 6 | 4 | 47 | 31 |
| Cash Flow from Operating Activities | -14 | 19 | 41 | -7 | 7 | 31 | 76 | -11 | 44 |
| Cash Flow from Investing Activities | -6 | -2 | -11 | -6 | -5 | -5 | -140 | 25 | -60 |
| Cash Flow from Financing Activities | 18 | -16 | -30 | 17 | -0 | -29 | 107 | -29 | 1 |
| Net Cash Inflow / Outflow | -1 | 1 | -0 | 4 | 1 | -2 | 43 | -15 | -15 |
| Closing Cash & Cash Equivalent | 0 | 1 | 1 | 5 | 6 | 4 | 47 | 31 | 16 |
| # | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.91 | 7.27 | 4.08 | 7.39 | 12.61 | 17.32 | 7.87 | 16.34 | 16.81 |
| CEPS(Rs) | 3.43 | 8.58 | 4.99 | 9.82 | 14.44 | 18.99 | 9.35 | 18.41 | 18.85 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.1 |
| Book NAV/Share(Rs) | 9.71 | 16.98 | 26.78 | 34.2 | 48.11 | 65.47 | 101.67 | 118.6 | 134.85 |
| Core EBITDA Margin(%) | 8.31 | 12.74 | 4.81 | 9.65 | 9.25 | 9.45 | 6.73 | 9.8 | 8.45 |
| EBIT Margin(%) | 8.04 | 13.13 | 6.4 | 10.69 | 10.49 | 10.46 | 7.06 | 10.75 | 9.55 |
| Pre Tax Margin(%) | 5.79 | 11.32 | 4.79 | 9.46 | 9.37 | 9.78 | 6.46 | 10.6 | 9.47 |
| PAT Margin (%) | 3.67 | 7.43 | 3.49 | 6.62 | 7.04 | 7.24 | 4.81 | 7.87 | 7.06 |
| Cash Profit Margin (%) | 4.35 | 8.02 | 3.96 | 7.15 | 7.47 | 7.68 | 5.49 | 8.51 | 7.59 |
| ROA(%) | 8.96 | 22.14 | 10.15 | 16.03 | 18.19 | 20.21 | 8.61 | 14.11 | 12.87 |
| ROE(%) | 29.77 | 59.59 | 20.1 | 29.78 | 33.03 | 31.53 | 10.6 | 15.47 | 13.82 |
| ROCE(%) | 21.63 | 44.86 | 21.03 | 29.05 | 29.93 | 31.28 | 13.65 | 20.78 | 18.59 |
| Receivable days | 53.02 | 48.06 | 47.07 | 58.59 | 54.96 | 48.94 | 63.49 | 55.64 | 58.69 |
| Inventory Days | 50.52 | 40.77 | 39.65 | 39.48 | 40.77 | 44.69 | 43.6 | 35.96 | 38.12 |
| Payable days | 5.26 | 5.56 | 4.36 | 5.38 | 4.6 | 3.94 | 5.5 | 6.72 | 6.27 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 21.86 | 18.41 | 18.37 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 1.69 | 2.54 | 2.29 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.33 | 0.36 |
| EV/Net Sales(x) | 0.25 | 0.15 | 0.13 | 0.16 | 0.14 | 0.12 | 0.81 | 1.27 | 1.21 |
| EV/Core EBITDA(x) | 2.9 | 1.12 | 1.93 | 1.44 | 1.3 | 1.14 | 10.14 | 11.12 | 12.01 |
| Net Sales Growth(%) | 0 | 35.75 | 17.67 | 8.99 | 40.78 | 28.03 | -14.9 | 27 | 14.74 |
| EBIT Growth(%) | 0 | 121.69 | -42.65 | 82.01 | 38.12 | 27.66 | -42.58 | 93.47 | 1.94 |
| PAT Growth(%) | 0 | 175.12 | -44.69 | 106.4 | 49.75 | 31.69 | -43.46 | 107.92 | 2.83 |
| EPS Growth(%) | 0 | 149.94 | -43.84 | 80.9 | 70.68 | 37.34 | -54.54 | 107.46 | 2.91 |
| Debt/Equity(x) | 2.02 | 0.96 | 0.62 | 0.69 | 0.62 | 0.34 | 0.03 | 0 | 0.01 |
| Current Ratio(x) | 1.57 | 1.98 | 2.23 | 2.07 | 2.2 | 3.34 | 9.98 | 19.91 | 18.64 |
| Quick Ratio(x) | 0.95 | 1.24 | 1.38 | 1.49 | 1.33 | 1.99 | 8.57 | 14.91 | 15.07 |
| Interest Cover(x) | 3.57 | 7.25 | 3.96 | 8.73 | 9.42 | 15.33 | 11.76 | 73.33 | 116.58 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.01 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 |
| FII | 6.33 | 6.61 | 6.04 | 6.09 | 6.05 | 4.32 | 3.2 | 3.28 | 3.21 | 3.77 |
| DII | 3.64 | 3.77 | 3.93 | 3.7 | 3.49 | 3.15 | 3.49 | 3.46 | 3 | 2.12 |
| Public | 19.04 | 18.63 | 19.03 | 19.22 | 19.47 | 21.53 | 22.31 | 22.27 | 22.8 | 23.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 |
| FII | 0.25 | 0.26 | 0.24 | 0.24 | 0.24 | 0.17 | 0.13 | 0.13 | 0.13 | 0.15 |
| DII | 0.14 | 0.15 | 0.15 | 0.14 | 0.14 | 0.12 | 0.14 | 0.14 | 0.12 | 0.08 |
| Public | 0.75 | 0.73 | 0.75 | 0.75 | 0.76 | 0.84 | 0.87 | 0.87 | 0.89 | 0.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +15% | +7% | +17% | — |
| Operating Profit CAGR | +1% | +5% | +15% | — |
| PAT CAGR | +3% | +7% | +19% | — |
| Share Price CAGR | +46% | — | — | — |
| ROE Average | +14% | +13% | +21% | +27% |
| ROCE Average | +19% | +18% | +23% | +26% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 | 70.99 |
| FII | 6.33 | 6.61 | 6.04 | 6.09 | 6.05 | 4.32 | 3.2 | 3.28 | 3.21 | 3.77 |
| DII | 3.64 | 3.77 | 3.93 | 3.7 | 3.49 | 3.15 | 3.49 | 3.46 | 3 | 2.12 |
| Public | 19.04 | 18.63 | 19.03 | 19.22 | 19.47 | 21.53 | 22.31 | 22.27 | 22.8 | 23.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 | 2.78 |
| FII | 0.25 | 0.26 | 0.24 | 0.24 | 0.24 | 0.17 | 0.13 | 0.13 | 0.13 | 0.15 |
| DII | 0.14 | 0.15 | 0.15 | 0.14 | 0.14 | 0.12 | 0.14 | 0.14 | 0.12 | 0.08 |
| Public | 0.75 | 0.73 | 0.75 | 0.75 | 0.76 | 0.84 | 0.87 | 0.87 | 0.89 | 0.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.